Growing Risks of Medication Errors Fuel the Europe Pharmacy Automation Systems Market
Medication errors are alarming and are considered the third leading cause of death worldwide. As per WHO, medication errors and unsafe drug practices are the main causes of preventable injury in healthcare systems worldwide. Fifty percent of medical care's avoidable harm is linked to medication, with the biggest contributors being errors in prescription and monitoring. Medication errors are expected to cost US$ 42 billion a year globally and a medication error causes 1 death in 1 million of the population globally. An article published by the European Alliance for Access to Safe Medicines in September 2022 states that medication errors result in 160,000 deaths annually in Europe. Also, countries such as the US, Spain, and Germany collectively report 60,000-131,000 deaths yearly due to medication errors. On the other hand, the risks of drug-related injuries due to medication errors are much higher. Distractions are the leading cause of ~75% of medication errors. Distractions are common when healthcare professionals are engaged in multiple tasks, including speaking to consultants, speaking to patient family members, examining the patient, and conversing with insurance professionals simultaneously. Moreover, in these situations, they fail to complete their duties on time and suffer a lapse of judgment, leading to medication errors. Distortion is another factor responsible for the maximum number of medication errors. Distortion is a result of poor writing, use of abbreviations, misunderstood symbols, or improper translation. Further, pharmacists and nurses find difficulties to understand the handwritten prescription for medicines that leads to wrong delivery of medicines to the patients. Thus, the growing number of medication errors triggers the demand for pharmacy automation systems.Europe Pharmacy Automation Systems Market Overview
The European pharmacy automation market is segmented into Germany, the UK, Italy, Spain, France, and the Rest of Europe. The presence of numerous domestic market players and the increasing incidences of chronic diseases are the key factors driving the market growth in this region. Germany is one of the major contributors to the global pharmacy automation systems market. The country has the presence of many players that develop and manufacture medical devices, along with their accessories required in the healthcare industry. In addition, several medical dispenser manufacturers operate in Germany. For instance, 12,000 BD Row systems developed in Germany by BD are installed worldwide. Similarly, various other players in the country are developing innovative automated pharmacy systems.Europe Pharmacy Automation Systems Market Segmentation
The Europe pharmacy automation systems market is segmented based on type, end user, and country.Based on type, the Europe pharmacy automation systems market is segmented into automation medication dispensing systems (product type and operation), automated packaging and labelling systems, automated table-top counters, automated storage and retrieval systems, and other types. The automation medication dispensing systems segment held the largest market share in 2022.
Based on end user, the Europe pharmacy automation systems market is segmented into hospital pharmacy, retail pharmacy, and others. The hospital pharmacy segment held the largest market share in 2022.
Based on country, the Europe pharmacy automation systems market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe pharmacy automation systems market share in 2022.
McKesson Corp, Becton Dickinson and Co, Capsa Solutions LLC, Deenova Srl, Omnicell Inc, Oracle Corp, Veradigm LLC, and Swisslog Healthcare AG are some of the leading companies operating in the Europe pharmacy automation systems market.
Table of Contents
Companies Mentioned
- McKesson Corp
- Becton Dickinson and Co
- Capsa Solutions LLC
- Deenova Srl
- Omnicell Inc
- Oracle Corp
- Veradigm LLC
- Swisslog Healthcare AG
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 94 |
Published | February 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value in 2022 | 3274.12 Million |
Forecasted Market Value by 2030 | 6848.48 Million |
Compound Annual Growth Rate | 9.7% |
Regions Covered | Europe |
No. of Companies Mentioned | 8 |